{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:02:59Z","timestamp":1769598179329,"version":"3.49.0"},"reference-count":32,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2015,4,30]]},"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To evaluate an immunohistochemical panel differentiating endometrial stromal sarcoma (ESS) from uterine leiomyosarcoma (ULMS) and leiomyoma (LM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>94 cases (28 ESS, 41 ULMS, 25 LM) were retrieved and arrayed. 10 immunomarkers (estrogen receptor (ER), progesterone receptor (PR), CD10, smooth muscle actin, desmin, h-caldesmon, transgelin, GEM, ASC1, stathmin1) were used. A predictive model was constructed and examined by receiver operating characteristics curve analysis to determine area under the curve (AUC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The combination of ER\n                      <jats:sup>+<\/jats:sup>\n                      \/PR\n                      <jats:sup>+<\/jats:sup>\n                      \/CD10\n                      <jats:sup>+<\/jats:sup>\n                      \/GEM\n                      <jats:sup>\u2212<\/jats:sup>\n                      \/h-caldesmon\n                      <jats:sup>\u2212<\/jats:sup>\n                      \/transgelin\n                      <jats:sup>\u2212<\/jats:sup>\n                      can predict ESS versus ULMS with AUC predictive value of 0.872 (95% CI 0.784 to 0.961, p&lt;0.0001). The combination of ER\n                      <jats:sup>+<\/jats:sup>\n                      \/PR\n                      <jats:sup>+<\/jats:sup>\n                      \/CD10\n                      <jats:sup>+<\/jats:sup>\n                      \/h-caldesmon\n                      <jats:sup>\u2212<\/jats:sup>\n                      \/transgelin\n                      <jats:sup>\u2212<\/jats:sup>\n                      can predict low grade (LG) ESS from \u2018LG\u2019 ULMS with AUC predictive value of 0.914 (95% CI 0.832 to 0.995, p&lt;0.0001). Finally, ULMS and ESS, including the LGs, were more likely to be stathmin1\n                      <jats:sup>+<\/jats:sup>\n                      than LM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Due to the different clinical course and management, adding novel antibodies (GEM, transgelin) to the well established immunohistochemistry panel seemed to be useful in distinguishing ESS from ULMS and LG ESS from \u2018LG\u2019 ULMS. Finally, stathmin1 expression could be of value in differentiating LM from uterine sarcomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jclinpath-2015-202915","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T23:15:46Z","timestamp":1432077346000},"page":"710-717","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":37,"title":["Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new"],"prefix":"10.1136","volume":"68","author":[{"given":"Helena","family":"Hwang","sequence":"first","affiliation":[{"name":"Department of Anatomic Pathology, University of Texas at Dallas, Dallas, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Division of Gynecology Oncology, Departments of Obstetrics and Gynecology, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Duncan","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Pakzamir","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huyen Q","family":"Pham","sequence":"additional","affiliation":[{"name":"Division of Gynecology Oncology, Departments of Obstetrics and Gynecology, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Correa","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Fedenko","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulette","family":"Mhawech-Fauceglia","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"key":"2025121219454916000_68.9.710.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2003.12.029"},{"key":"2025121219454916000_68.9.710.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2009.03231.x"},{"key":"2025121219454916000_68.9.710.3","unstructured":"Kurman RJ , Carcangiu ML , Herrington CS , et al . Mesenchymal tumours. WHO classification of tumours of female reproductive organs. 4th edn. Lyon: IARC Press, vol 6, 2014."},{"key":"2025121219454916000_68.9.710.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2012.01.021"},{"key":"2025121219454916000_68.9.710.5","first-page":"664","article-title":"Endometrial stromal sarcoma; experience from a district hospital and literature review","volume":"30","author":"Somoye","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"key":"2025121219454916000_68.9.710.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2011.07.004"},{"key":"2025121219454916000_68.9.710.7","doi-asserted-by":"publisher","DOI":"10.1177\/1758834013513314"},{"key":"2025121219454916000_68.9.710.8","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000205"},{"key":"2025121219454916000_68.9.710.9","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000261"},{"key":"2025121219454916000_68.9.710.10","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31820ca624"},{"key":"2025121219454916000_68.9.710.11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20521"},{"key":"2025121219454916000_68.9.710.12","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1038"},{"key":"2025121219454916000_68.9.710.13","doi-asserted-by":"publisher","DOI":"10.1097\/00129039-200412000-00008"},{"key":"2025121219454916000_68.9.710.14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24486"},{"key":"2025121219454916000_68.9.710.15","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880335"},{"key":"2025121219454916000_68.9.710.16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00129039-200106000-00009","article-title":"Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma","volume":"9","author":"Agoff","year":"2001","journal-title":"Appl Immunohist Mol Morphol"},{"key":"2025121219454916000_68.9.710.17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2001.01215.x"},{"key":"2025121219454916000_68.9.710.18","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200102000-00014"},{"key":"2025121219454916000_68.9.710.19","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200104000-00004"},{"key":"2025121219454916000_68.9.710.20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.5858\/2008-132-402-AOITGP","article-title":"Application of immunohistochemistry to gynecologic pathology","volume":"132","author":"Mittal","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"2025121219454916000_68.9.710.21","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200204000-00001"},{"key":"2025121219454916000_68.9.710.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.11.021"},{"key":"2025121219454916000_68.9.710.23","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.192"},{"key":"2025121219454916000_68.9.710.24","first-page":"26","article-title":"Transgelin, a novel marker of smooth muscle differentiation, effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors","volume":"1","author":"Tawfik","year":"2014","journal-title":"IJGORMR"},{"key":"2025121219454916000_68.9.710.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2004.01797.x"},{"key":"2025121219454916000_68.9.710.26","doi-asserted-by":"publisher","DOI":"10.1038\/35079621"},{"key":"2025121219454916000_68.9.710.27","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.15.4076"},{"key":"2025121219454916000_68.9.710.28","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199109000-00006"},{"key":"2025121219454916000_68.9.710.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1048-891X.2004.14610.x"},{"key":"2025121219454916000_68.9.710.30","doi-asserted-by":"publisher","DOI":"10.1038\/nm1560"},{"key":"2025121219454916000_68.9.710.31","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12417"},{"key":"2025121219454916000_68.9.710.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.05.021"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2015-202915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:45:59Z","timestamp":1765597559000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2015-202915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,8,18]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1136\/jclinpath-2015-202915"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2015-202915","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,19]]}}}